WFS1 and dysautonomia: The p.Phe354del alteration, previously described by Cano et al. (74), disrupts the first transmembrane domain of Wolframin and has been reported in a patient presenting neurogenic bladder, ataxia, dysautonomia, and psychiatric disturbances.